Lappe Mark - Insider Non-Derivative Transactions at Inhibrx Biosciences, Inc. (INBX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 16, 2024, Lappe Mark's relationship to Inhibrx Biosciences, Inc. (INBX) is Director,Officer (Chief Executive Officer), and currently has 705,548 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other INBX insiders.
Data Source: SEC.
Lappe Mark - Insider Non-Derivative Transactions of INBX Common Stock
Lappe Mark - Insider Non-Derivative Transactions at INBX
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
Sep 17, 2024 | P -- (Common Stock) | 13037 | 17.13 | 705548 |
Sep 13, 2024 | P -- (Common Stock) | 26963 | 15.05 | 692511 |
Sep 11, 2024 | P -- (Common Stock) | 8500 | 15.19 | 665548 |
Sep 10, 2024 | P -- (Common Stock) | 9500 | 15.21 | 657048 |
Sep 7, 2024 | P -- (Common Stock) | 26000 | 15.29 | 647548 |
Sep 4, 2024 | P -- (Common Stock) | 15288 | 15.66 | 160288 |
Sep 4, 2024 | P -- (Common Stock) | 4712 | 16.31 | 165000 |
Aug 31, 2024 | P -- (Common Stock) | 10000 | 14.02 | 145000 |
Aug 30, 2024 | P -- (Common Stock) | 10000 | 14.03 | 135000 |
Aug 22, 2024 | P -- (Common Stock) | 12945 | 12.93 | 54865 |
Aug 21, 2024 | P -- (Common Stock) | 27055 | 12.97 | 41920 |